Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.
Schoonenboom
Niki S M
NS
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. niki.schoonenboom@vumc.nl
Mulder
Cees
C
Vanderstichele
Hugo
H
Pijnenburg
Yolande A L
YA
Van Kamp
Gerard J
GJ
Scheltens
Philip
P
Mehta
Pankaj D
PD
Blankenstein
Marinus A
MA
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D003704:Dementia / Q000175:diagnosis; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D012372:ROC Curve; D012680:Sensitivity and Specificity
D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42)